Study Title
 |
Principal
Investigator |
Disease
Category |
 |
|
Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer
|
Dr. Sandy Srinivas
|
Prostatic Neoplasms
|
|
|
Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
|
Bruno Carneiro de Medeiros
|
Leukemia
|
|
|
Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
|
Steven Edward Coutre
|
Leukemia
|
|
|
Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder
|
Laura Johnston
|
Myeloproliferative Disorders
Leukemia
Lymphoma
Graft vs Host Disease
Myelodysplastic Syndromes
Multiple Myeloma
|
|
|
Cytarabine and Daunorubicin With or Without Gemtuzumab Ozogamicin Followed By High-Dose Cytarabine Followed By Either Gemtuzumab Ozogamicin or No Additional Therapy in Treating Patients With Previously Untreated De Novo Acute Myeloid Leukemia
|
Steven Edward Coutre
|
Leukemia
|
|
|
A Phase 2 Open Label Trial of SGN-35 for Systemic Anaplastic Large Cell Lymphoma
|
Michael Link
|
Lymphoma
Lymphoma, Non-Hodgkin
|
|
|
Reduced Duration Standford V Chemotherapy With Low-Dose Tailored-Field Radiation For Favorable Risk Pediatric Hodgkin Lymphoma
|
Michael Link
|
Lymphoma
|
|
|
Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer
|
Dr. Sandy Srinivas
|
Urogenital Cancer
|
|
|
A Study of Pemetrexed in Children With Recurrent Cancer
|
Dr. Neyssa Maria Marina
|
Osteosarcoma
Neuroblastoma
Medulloblastoma
|
|
|
Phase I Vorinostat Concurrent with Stereotactic Radiosurgery (SRS) in Brain Metastases from Non-Small Cell Lung Cancer
|
John R. Adler
|
Brain Cancer
Neoplasm Metastasis
Lung Cancer
|
|
|
A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients
|
Steven Edward Coutre
|
Multiple Myeloma
Bone Diseases
|
|
|
Phase II Intergroup Clinical Trial For Adolescents & Young Adults With Untreated ALL
|
Michaela Liedtke
|
Leukemia
|
|
|
An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome
|
George Albert Fisher M.D. Ph.D.
|
Carcinoid Tumor
|
|
|
Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients
|
George Albert Fisher M.D. Ph.D.
|
Gastrointestinal Stromal Tumors
|
|
|
Chemotherapy and Radiation Therapy With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer
|
Quynh-Thu Le
|
Head and Neck Cancer
|
|
|
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Solar Melanoma That Cannot Be Removed By Surgery
|
Harlan Pinto
Sunil Arani Reddy
|
Melanoma
|
|
|
A Phase 1 Dose Escalation Study of OMP-21M18 in Subjects With Solid Tumors
|
Branimir I Sikic
|
Carcinomas (including Squamous Cell and Adenocarcinoma)
|
|
|
A Study of ASA404 or Placebo in Combination With Docetaxel in Second-Line Treatment for (Stage IIIb/IV) Non-Small Cell Lung Cancer (ATTRACT-2)
|
Heather A. Wakelee
|
Lung Cancer
|
|
|
Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
|
Iris Catrice Gibbs
|
Brain Cancer
|
|
|
Phase I/II of Azacitidine + Lenalidomide for Previously Untreated Elderly Patients with Acute Myeloid Leukemia
|
Bruno Carneiro de Medeiros
Daniel Aaron Pollyea
|
Leukemia
|
|
|
Safety Study to Evaluate Monoclonal Antibody KW-0761 in Subjects With Peripheral T-Cell Lymphoma
|
Youn H Kim
|
Lymphoma, T-Cell
Lymphoma, T-Cell, Cutaneous
|
|
|
Imatinib Mesylate and Nilotinib After Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia
|
Laura Johnston
|
Leukemia
|
|
|
Phase 2 of Azixa™ (MPC-6827) for Glioblastoma Multiforme in First or Second Relapse
|
Dr Lawrence Recht
|
Brain Cancer
Glioblastoma
|
|
|
Genes in Predicting Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab and Combination Chemotherapy
|
Ronald Levy
|
Lymphoma
|
|
|
Safety Study of ABT-263 in Combination With Rituximab in Lymphoid Cancers
|
Sandra Jeane Horning
|
Lymphoma, Non-Hodgkin
Lymphoproliferative Disorders
|
|
|
An Open-Label, Dose Escalation, Phase 1 Study of MLN4924, a Novel Inhibitor of Nedd8-Activating Enzyme, in Adult Patients with Acute Myelogenous Leukemia and High-Grade Myelodysplastic Syndrome
|
Bruno Carneiro de Medeiros
|
Leukemia, Myeloid
|
|
|
Donor Stem Cell Transplant in Treating Patients With Relapsed Follicular Non-Hodgkin Lymphoma After First Complete Remission
|
Ginna Laport
|
Lymphoma
Lymphoma, Non-Hodgkin
|
|
|
A Phase II Intratumoral Injection PF-3512676 plus Local Radiation in Low-Grade B-Cell Lymphomas
|
Ronald Levy
|
Lymphoma
|
|
|
Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia
|
Gary V Dahl
|
Leukemia
Leukemia, Myeloid
|
|
|
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
|
Irene L. Wapnir
|
Breast Cancer
Carcinoma, Intraductal, Noninfiltrating
|
|
|
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
|
Peter L Greenberg
|
Leukemia
Carcinomas (including Squamous Cell and Adenocarcinoma)
Myelodysplastic Syndromes
|
|
|
Docetaxel, Cisplatin, Fluorouracil, Bevacizumab, and Radiation Therapy in Treating Patients With Advanced Nasopharyngeal Carcinoma
|
Dr. A. Dimitrios Colevas
|
Head and Neck Cancer
|
|
|
A Pivotal Open-Label Trial of SGN-35 for Hodgkin Lymphoma
|
Sandra Jeane Horning
|
Lymphoma, Hodgkin Disease
Hodgkin Disease
|
|
|
Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer
|
Dr. Sandy Srinivas
|
Kidney Diseases
Carcinoma, Renal Cell
|
|
|
Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer
|
Amreen Husain
|
Endometrial Neoplasms
|
|
|
Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma
|
Kristen N. Ganjoo
|
Sarcoma
|
|
|
Pre-Surgical Detection of Clear Cell Renal Cell Carcinoma Using Radiolabeled G250-Antibody
|
Benjamin I. Chung
|
Kidney Neoplasms
Carcinoma, Renal Cell
|
|
|
Ph II, Multicenter, Simon 2-Stage of R788 For Relapsed or Refractory T-Cell Lymphoma
|
Ranjana Hira Advani
|
Lymphoma, T-Cell
|
|
|
BIBW 2992 With or Without Daily Temozolomide For Recurrent Malignant Glioma
|
Dr Lawrence Recht
|
Oligodendroglioma
Glioma
Glioblastoma
|
|
|
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
|
Harlan Pinto
|
Head and Neck Cancer
|
|
|
A Phase 1/2 Study of Aflibercept Administered in Combination with Pemetrexed and Cisplatin in Patients with Advanced Carcinoma
|
Heather A. Wakelee
|
Carcinoma, Non-Small-Cell Lung
|
|
|
Combination Study Of SB-485232 (Interleukin 18) And Doxil For Advanced Stage Epithelial Ovarian Cancer
|
Jonathan S. Berek MD, MMS
|
Ovarian Cancer
|
|
|
Phase II, Multi-Center, Single-Arm, Two-Cohort Trial of GDC-0449 for Advanced Basal Cell Carcinoma
|
Anthony Oro
Dr. Anne Lynn S. Chang
|
Carcinoma, Basal Cell
Skin Cancers
|
|
|
Phase 3 Efficacy Study of XL184 in Adults With Medullary Thyroid Cancer
|
Dr. A. Dimitrios Colevas
|
Neuroendocrine Tumors
Thyroid Cancer
|
|
|
Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma
|
Susan M. Swetter
|
Melanoma
Dysplastic Nevus Syndrome
|
|
|
Phase II Gemcitabine, Carboplatin & PARP Inhibitor BSI-201 in Neoadjuvant Tx of Triple-Neg Breast CA
|
Allison Walsh Kurian
|
Breast Cancer
|
|
|
Ph I/II of Vitamin D on Bone Mineral Density & Markers of Bone Resorption
|
Eva Balint
Robert W Carlson
|
Breast Cancer
Bone Diseases
|
|
|
A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL Amyloidosis
|
Stanley L Schrier
|
Leukemia
Amyloidosis
|
|
|
Phase I Dose-Escalation Study of Btk Inhibitor PCI-32765 in Recurrent B Cell Lymphoma
|
Ranjana Hira Advani
|
Lymphoma, Non-Hodgkin
Leukemia, Lymphocytic, Chronic
Lymphoma, Small-Cell
|
|
|
Phase I/II Combination 5-azacitidine and Gemtuzimab Ozogamycin for Relapsed AML
|
Bruno Carneiro de Medeiros
|
Leukemia, Myelocytic, Acute
|
|
|
Vorinostat and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
|
Bruno Carneiro de Medeiros
|
Leukemia
|
|
|
AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate Cancer
|
Dr. Sandy Srinivas
|
Prostatic Neoplasms
|
|
|
AZD0530 in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer
|
Heather A. Wakelee
|
Thymoma
Thymus Neoplasms
|
|
|
Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies
|
Steven Edward Coutre
|
Lymphoma, Non-Hodgkin
Leukemia, Lymphocytic, Chronic
|
|
|
Safety and Efficacy of RAD001 in Patients With Velcade® Refractory Mantle Cell Lymphoma
|
Ranjana Hira Advani
|
Lymphoma, Mantle-Cell
|
|
|
Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML
|
Steven Edward Coutre
|
Leukemia, Myeloid, Chronic
|
|
|
Study to Determine Efficacy and Safety of Lenalidomide Plus Low-Dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma (FIRST)
|
Steven Edward Coutre
|
Multiple Myeloma
|
|
|
A Study of XL184 With or Without Erlotinib in Adults With Non-Small Cell Lung Cancer
|
Heather A. Wakelee
|
Carcinoma, Non-Small-Cell Lung
|
|
|
Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries
|
Amreen Husain
|
Ovarian Cancer
Osteoporosis
Breast Cancer
|
|
|
Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
|
Amreen Husain
|
Ovarian Cancer
Fallopian Tube Neoplasms
Peritoneal Neoplasms
|
|
|
Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma
|
George Albert Fisher M.D. Ph.D.
|
Stomach Cancer
|
|
|
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
|
Dr Andrew Shelton
|
Rectal Cancer
Colorectal Neoplasms
Anal, Colon, and Rectal Cancers
|
|
|
CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Normal Estradiol
|
Heather A. Wakelee
|
Lung Cancer
|
|
|
Ph II of Single-Agent Enzastaurin for Relapsed Cutaneous T-Cell Lymphoma
|
Youn H Kim
|
Lymphoma, T-Cell
|
|
|
Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI
|
Dr Andrew Quon
|
Kidney Neoplasms
Carcinoma, Renal Cell
|
|
|
A Phase 1 Study of an Oral VEGFR Inhibitor (AV-951) in Combination With Torisel in Renal Cell Cancer
|
Dr. Sandy Srinivas
|
Carcinoma, Renal Cell
|
|
|
Randomized Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
|
Dr. Sandy Srinivas
|
Bladder Cancer
|
|
|
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
|
Dr. Neyssa Marina
|
Neuroblastoma
|
|
|
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
|
Dr. Neyssa Marina
|
Sarcoma
|
|
|
High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without a Biological Inhibitor in Treating Patients with Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
|
Dr. Billy W. Loo Jr. M.D. Ph.D.
|
Lung Cancer
|
|
|
Ph I Dose-Escalation of AEG40826-2HCI for Advanced Solid Tumors
|
Branimir I Sikic
|
Brain Cancer
Cancer
|
|
|
AZD6244 in Treating Woman With Recurrent Low-Grade Ovarian Cancer
|
Amreen Husain
|
Ovarian Cancer
|
|
|
A Study of Carboplatin and Gemcitabine Plus Bevacizumab in Patients With Ovary, Peritoneal, or Fallopian Tube Carcinoma (OCEANS)
|
Jonathan S. Berek MD, MMS
|
Ovarian Cancer
|
|
|
Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
|
Dr. Neyssa Marina
|
Ovarian Cancer
Neoplasms, Germ Cell and Embryonal
|
|
|
Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites
|
Jonathan S. Berek MD, MMS
|
Ovarian Cancer
Ascites
|
|
|
Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project
|
Dr Andrew Quon
|
Colorectal Neoplasms
Anal, Colon, and Rectal Cancers
|
|
|
Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia
|
Dr. Neyssa Marina
|
Leukemia
|
|
|
Gemtuzumab and Combination Chemothearpy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
|
Steven Edward Coutre
|
Leukemia
|
|
|
Dasatinib for CML or Philadelphia Chromosome Positive ALL previously on START protocols
|
Steven Edward Coutre
|
Leukemia, Myeloid, Chronic
|
|
|
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
|
Steven Edward Coutre
|
Leukemia
Leukemia, Myeloid
Leukemia, Myelocytic, Acute
Lymphoma, T-Cell, Cutaneous
|
|
|
A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Second-Line Treatment of Patients With DLBCL
|
Ranjana Hira Advani
|
Lymphoma, Diffuse
Lymphoma, B-Cell
Lymphoma, Non-Hodgkin
|
|
|
Development of Vitamin D as a Therapy for Breast Cancer - Phase II
|
Robert W Carlson
|
Breast Cancer
|
|
|
Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia
|
Bruno Carneiro de Medeiros
|
Leukemia, Myeloid
|
|
|
Phase 1 Trial of Oral Ixabepilone
|
Branimir I Sikic
|
Carcinomas (including Squamous Cell and Adenocarcinoma)
|
|
|
BIBW 2992 in Head&Neck Cancer
|
Dr. A. Dimitrios Colevas
|
Head and Neck Cancer
Carcinoma, Squamous Cell
|
|
|
Study of Pralatrexate and Gemcitabine With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Lymphoproliferative Malignancies
|
Ranjana Hira Advani
|
Lymphoma, Hodgkin Disease
Hodgkin Disease
Lymphoma, Non-Hodgkin
|
|
|
Phase III Study of Aflibercept vs Placebo for Metastatic Androgen-Independent Prostate Cancer
|
Dr. Sandy Srinivas
|
Prostatic Neoplasms
Neoplasm Metastasis
|
|
|
Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant Neuroblastoma
|
Clare J. Twist M.D.
|
Neuroblastoma
|
|
|
Forodesine in the Treatment of Cutaneous T-Cell Lymphoma
|
Youn H Kim
|
Lymphoma, T-Cell
|
|
|
Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma
|
Youn H Kim
|
Lymphoma, T-Cell, Cutaneous
|
|
|
Study of Bexxar Combined With External Beam Radiation Therapy for Patients With Relapsed, Bulky Non-Hodgkin's Lymphoma
|
Susan J Knox
|
Lymphoma, Non-Hodgkin
|
|
|
Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A
|
Youn H Kim
|
Lymphoma, T-Cell, Cutaneous
|
|
|
Treatment of Refractory Metastatic Renal Cell Carcinoma with Bevacizumab and RADOO1
|
Dr. Sandy Srinivas
|
Kidney Neoplasms
|
|
|
Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotexate or Observation in Treating Patients With Acute Promyelocytic Leukemia
|
Steven Edward Coutre
|
Leukemia
|
|
|
Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease
|
Steven Edward Coutre
|
Leukemia, Hairy Cell
|
|
|
Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL (STAR-1)
|
Steven Edward Coutre
|
Leukemia, Promyelocytic, Acute
|
|
|
Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia
|
Steven Edward Coutre
|
Leukemia, Lymphocytic, Acute
|
|
|
Temsirolimus and Sorafenib as Second-Line Therapy in Patients With Advanced RCC Who Failed First-Line Sunitinib
|
Dr. Sandy Srinivas
|
Kidney Neoplasms
Carcinoma, Renal Cell
|
|
|
Phase II Temozolomide in Acute Myeloid Leukemia Patient Age >= 60 Yrs & Poor Risk/Refractory Disease
|
Bruno Carneiro de Medeiros
|
Leukemia, Myeloid
|
|
|
A Phase II Study of GSK1363089 (Formerly XL880) for Metastatic Gastric Cancer
|
James M Ford
|
Stomach Cancer
|
|
|
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
|
Robert W Carlson
|
Breast Cancer
|
|
|
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
|
Dr. Neyssa Marina
|
Leukemia
|
|
|
Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
|
Irene L. Wapnir
|
Breast Cancer
|
|
|
Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
|
Amreen Husain
|
Endometrial Neoplasms
|
|
|
Low-Dose Radiation Therapy and Combination Chemotherapy Following Surgery in Treating Children With Newly Diagnosed Primitive Neuroectodermal Tumor or Medulloblastoma
|
Paul Graham Fisher
|
Central Nervous System Neoplasms
Brain Cancer
Neuroectodermal Tumors
Medulloblastoma
|
|
|
Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma
|
Dr. Neyssa Marina
|
Neuroblastoma
|
|
|
Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma
|
Sandra Jeane Horning
|
Lymphoma
Lymphoma, Hodgkin Disease
Hodgkin Disease
|
|
|
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
|
Dr. Neyssa Marina
|
Sarcoma
|
|
|
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-Small Cell Lung Cancer
|
Harlan Pinto
|
Lung Cancer
|
|
|
Phase III CHOP + Rituximab vs CHOP + Iodine-131 Monoclonal Anti-B1 Antibody for New Dx Foll NHL
|
Sandra Jeane Horning
|
Lymphoma
|
|
|
Melphalan and Buthionine Sulfoximine Followed by Stem Cell Transplantation in Children With Resistant or Recurrent Neuroblastoma
|
Clare J. Twist M.D.
|
Neuroblastoma
|
|
|
Ph III Randomized Study of Four Weeks of High-Dose IFN-á2b for Microscopic Melanoma
|
Harlan Pinto
|
Melanoma
Skin Cancers
|
|
|
Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer
|
Dr. Sandy Srinivas
|
Prostatic Neoplasms
|
|
|
Phase II study of Atorvastatin safety and antitumor effects in non-Hodgkin's Lymphoma
|
Dean Felsher
|
Leukemia
Lymphoma, Non-Hodgkin
|
|
|
Phase II Study of Bexxar in Relapsed/Refractory Diffuse Large Cell Lymphoma
|
Susan J Knox
|
Lymphoma, Non-Hodgkin
Lymphoma, Large-Cell, Diffuse
|
|
|
Phase II PKC412 in Aggressive Systemic Mastocytosis and Mast Cell Leukemia
|
Jason Robert Gotlib
|
Myeloproliferative Disorders
Mastocytosis, Systemic
Leukemia, Mast-Cell
|
|
|
Phase II Poor Risk Diffuse Large B-cell Lymphoma (DLBCL) of Total Lymphoid Irradiation (TLI) and Antithymocyte Globulin (ATG) Followed by Matched Allogeneic Hematopoietic Transplantation as Consolidation to Autologous Hematopoietic Cell Transplantation (AHCT)
|
Sandra Jeane Horning
|
Lymphoma, B-Cell
|
|
|
Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease
|
Sandra Jeane Horning
|
Lymphoma
Lymphoma, Hodgkin Disease
Hodgkin Disease
|
|
|
Phase II Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel with Lapatinib in Stage II/III Her2Neu+ Breast Cancer
|
Dr. Ellie Guardino MD/PhD
|
Breast Cancer
|
|
|
Phase II Anastrozole and ZD6474 in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer
|
Dr. Ellie Guardino MD/PhD
|
Breast Cancer
|
|
|
Phase II Gemzar, Taxol & Avastin Combination as 1st Line Tx for Metastatic Breast CA
|
Dr. Ellie Guardino MD/PhD
|
Breast Cancer
|
|
|
Phase I Oral mTOR Inhibitor RAD001 in Combo w/ Capecitabine for Metastatic Breast
|
Dr. Ellie Guardino MD/PhD
|
Breast Cancer
|
|
|
Phase II Trial - Breast Cancer Chemoprevention by Lovastatin
|
James M Ford
|
Breast Cancer
|
|
|
Phase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine Tumors
|
George Albert Fisher M.D. Ph.D.
|
Neuroendocrine Tumors
|
|
|
Phase II Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy
|
Quynh-Thu Le
|
Head and Neck Cancer
Carcinoma, Squamous Cell
|
|
|
Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary CNS Germ Cell Tumor
|
Dr. Neyssa Marina
|
Central Nervous System Neoplasms
Brain Cancer
|
|
|
Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes
|
Dr. Neyssa Marina
|
Leukemia
|
|
|
Therapy for Pediatric Hodgkin Lymphoma
|
Michael Link
|
Lymphoma, Hodgkin Disease
Hodgkin Disease
|
|
|
Iodine I 131 Metaiodobenzylguanidine, Combination Chemotherapy, and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell or Bone Marrow Transplant for Relapsed or Refractory Neuroblastoma
|
Clare J. Twist M.D.
|
Neuroblastoma
|
|
|
Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
|
Amreen Husain
|
Uterine Neoplasms
Uterine Cervical Neoplasms
Adenocarcinoma
Carcinoma, Squamous Cell
|
|
|
Study to Assess Compliance With Long-Term MercaptopurineTreatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
|
Dr. Neyssa Marina
|
Leukemia
|
|
|
Clinical Trial of PXD101 in Patients With T-Cell Lymphomas
|
Ranjana Hira Advani
|
Lymphoma, T-Cell
|
|
|
Azacitidine With or Without MS-275 in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
|
Peter L Greenberg
|
Leukemia
Bone Marrow Neoplasms
|
|
|
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
|
Heather A. Wakelee
|
Lung Cancer
|
|
|
Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery
|
Dr. Sandy Srinivas
|
Kidney Neoplasms
Carcinoma, Renal Cell
|
|
|
Ixabepilone in Treating Young Patients With Refractory Solid Tumors
|
Dr. Neyssa Marina
|
Sarcoma
Wilms Tumor
Neuroblastoma
|
|
|
Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma
|
Sandra Jeane Horning
|
Brain Cancer
Lymphoma
|
|
|
Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin's Disease
|
Michael Link
|
Lymphoma
|
|
|
Vincristine and Dactinomycin With or Without Doxorubicin and Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
|
Dr. Neyssa Marina
|
Wilms Tumor
|
|
|
Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
|
Irene L. Wapnir
|
Breast Cancer
|
|
|
Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD)
|
Laura Johnston
|
Leukemia, Myelocytic, Acute
Myelodysplastic Syndromes
|
|
|
Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL)
|
Clare J. Twist M.D.
|
Leukemia, Lymphocytic, Acute
|
|
|
Lenalidomide in Treating Patients With Relapsed Mycosis Fungoides/Sezary Syndrome
|
Youn H Kim
|
Lymphoma
Lymphoma, Non-Hodgkin
|
|
|
Study of XL518 in Adults With Solid Tumors
|
Branimir I Sikic
|
Carcinomas (including Squamous Cell and Adenocarcinoma)
|
|
|
SARC 009: A Phase II Trial of Dasatinib in Advanced Sarcomas
|
Kristen N. Ganjoo
|
Hemangiopericytoma
Nerve Sheath Neoplasms
Rhabdomyosarcoma
Chordoma
|
|
|
Study of XL880 in Subjects With Papillary Renal Cell Carcinoma
|
Dr. Sandy Srinivas
|
Carcinoma, Papillary
Kidney Neoplasms
Carcinoma, Renal Cell
|
|
|
Phase I Vandetanib plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer
|
Branimir I Sikic
|
Colorectal Neoplasms
Anal, Colon, and Rectal Cancers
|
|
|
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
|
Irene L. Wapnir
|
Breast Cancer
|
|
|
Irinotecan and Vincristine for Radiosensitization of 131I-MIBG Therapy for High-Risk Neuroblastoma
|
Clare J. Twist M.D.
|
Neuroblastoma
|
|
|
A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I)
|
Bruno Carneiro de Medeiros
|
Leukemia, Myelocytic, Acute
|
|
|
An Observational Study of the Ethnic Impact of Patients Undergoing 2nd Line Treatment for Non-Small Cell Lung Cancer Using Pemetrexed
|
Heather A. Wakelee
|
Lung Cancer
|
|
|
A Phase I Dose Escalation Study of Weekly SGN-35 Alone and in Combination With Gemcitabine in HL
|
Sandra Jeane Horning
|
Lymphoma, Hodgkin Disease
Hodgkin Disease
Blood Cancer
|
|
Study Title
|
Principal
Investigator |
Disease
Category |
|
|
Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
|
Irene L. Wapnir
|
Breast Cancer
|
|
|
Real-Time kV Imaging vs. Real-Time 3D Patient Surface Tracking for Head & Neck Cancer
|
Quynh-Thu Le
|
Head and Neck Cancer
|
|
|
Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors
|
Kate R Lorig
|
Breast Cancer
Prostatic Neoplasms
Colorectal Neoplasms
Anal, Colon, and Rectal Cancers
Blood Cancer
|
|
|
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
|
James M Ford
|
Digestive System Neoplasms
|
|
|
Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors
|
Paul J Keall
Amit Sawant
|
Pancreatic Cancer
Liver Cancer
Lung Cancer
|
|
|
Collecting Tumor Samples From Patients With Gynecological Tumors
|
Amreen Husain
|
Ovarian Cancer
|
|
|
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia
|
Dr. Neyssa Maria Marina
|
Leukemia
|
|
|
MRI Imaging of the Human Larynx
|
Edward J. Damrose MD, FACS
|
Laryngeal Neoplasms
|
|
|
Phase I/II Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases
|
Scott Soltys
Clara Choi
|
Brain Cancer
Neoplasm Metastasis
|
|
|
Ph II of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG
|
Wen-Kai Weng
|
Transplantation, Homologous
Transplantation, Autologous
Multiple Myeloma
|
|
|
Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
|
Joseph B. Shrager
|
Lung Cancer
|
|
|
Clinical and Pathologic Studies of Patients Undergoing Treatment with EGFR Inhibitors
|
George Albert Fisher M.D. Ph.D.
Russell Pachynski
|
Head and Neck Cancer
Colorectal Neoplasms
Anal, Colon, and Rectal Cancers
Colonic Neoplasms
Lung Cancer
Colon Cancer
|
|
|
Identification of Key Blood Molecular Markers for Immunotherapy
|
Jeffrey A. Norton
|
Carcinomas (including Squamous Cell and Adenocarcinoma)
|
|
|
Ph II of Non-myeloablative Allgnc Trnsplnt Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma
|
Wen-Kai Weng
|
Sezary Syndrome
Mycoses
Lymphoma, T-Cell, Cutaneous
|
|
|
GSK1572932A Antigen-Specific Cancer Immunotherapeutic as adjuvant therapy for NSCLC
|
Joseph B. Shrager
|
Carcinoma, Non-Small-Cell Lung
|
|
|
Immunobiology of Breast Cancer
|
Peter P Lee
|
Breast Cancer
|
|
|
B-Receptor Signaling in Cardiomyopathy
|
Daniel Bernstein
|
Carcinomas (including Squamous Cell and Adenocarcinoma)
|
|
|
Immunobiology of Cancer
|
Peter P Lee
|
Carcinomas (including Squamous Cell and Adenocarcinoma)
|
|
|
Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
|
Dr. Billy W. Loo Jr. M.D. Ph.D.
|
Lung Cancer
|
|
|
Permission to Collect Blood over Time for Research
|
Haruka Itakura
|
Gastrointestinal Neoplasms
Pancreatic Cancer
|
|
|
Prostate Active Surveillance Study (PASS)
|
James D Brooks
|
Prostatic Neoplasms
|
|
|
Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery
|
Dr. Billy W. Loo Jr. M.D. Ph.D.
|
Lung Cancer
|
|
|
Combined F18 and F18 FDG PET/CT for Evaluation of Malignancy
|
Sanjiv Sam Gambhir M.D., Ph.D.
|
Carcinomas (including Squamous Cell and Adenocarcinoma)
|
|
|
Use of otoscope as a non-invasive tool for diagnosis of pilomatricoma
|
Alfred T Lane
Odmara Liz Barreto-Chang
|
Pilomatrixoma
|
|
|
Second Curettage in Treating Patients With Persistent Non-Metastatic Gestational Trophoblastic Tumor
|
Amreen Husain
|
Gestational Trophoblastic Neoplasms
|
|
|
18 F-fluoride PET/CT versus 99Tc-MDP Scanning for Detecting Bone Metastases
|
Sanjiv Sam Gambhir M.D., Ph.D.
|
Breast Cancer
Prostatic Neoplasms
Bone Cancer
Lung Cancer
|
|
|
AEWS07B1: A COG Study for Collecting and Banking Ewing Sarcoma Specimens
|
Dr. Neyssa Marina
|
Sarcoma
|
|
|
A Children’s Oncology Group Protocol for Collecting and Banking Osteosarcoma Specimens
|
Dr. Neyssa Marina
|
Osteosarcoma
|
|
|
Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CT
|
Irene L. Wapnir
|
Breast Cancer
|
|
|
Chronic GVHD Cohort Protocol
|
Sally Arai
|
Carcinomas (including Squamous Cell and Adenocarcinoma)
|
|
|
Biopsy of human tumors for cancer stem cell characterization: a feasibility study
|
Dr. A. Dimitrios Colevas
|
Head and Neck Cancer
|
|
|
Breast Density and the Role of Preoperative Mammography, Ultrasound, Elastography and MRI
|
Debra M Ikeda
|
Breast Cancer
|
|
|
Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer
|
Irene L. Wapnir
|
Breast Cancer
|
|
|
Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
|
Albert Koong
|
Carcinomas (including Squamous Cell and Adenocarcinoma)
|
|
|
Quality of Life Following Radical Prostatectomy
|
Joseph C. Presti Jr.
|
Prostatic Neoplasms
|
|
|
Microarray Analysis of Gene Expression in Prostate Tissues
|
James D Brooks
|
Prostatic Neoplasms
|
|
|
Phase I/II of a CpG-Activated Whole Cell Vaccine Followed by Autologous “Immunotransplant” for MCL
|
Ronald Levy
|
Lymphoma, Mantle-Cell
|
|
|
Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
|
Ronald Levy
|
Lymphoma, Non-Hodgkin
|
|
|
PET/CT and Whole-Body MRI for Detection of Skeletal and Soft Tissue Metastases
|
Sanjiv Sam Gambhir M.D., Ph.D.
|
Sarcoma and Soft Tissue Cancers
Bone Cancer
Neoplasm Metastasis
|
|
|
Bone Marrow Grafting for Leukemia and Lymphoma
|
Robert S Negrin
David Miklos
|
Leukemia
Lymphoma
Hematologic Diseases
|
|
|
Molecular Genetic and Pathological Studies of Anal Tumors
|
Mark Lane Welton
|
Rectal Cancer
Anal Cancer
Colonic Neoplasms
Colon Cancer
|
|
|
Allogeneic Transplantation From Related Haploidentical Donors in Older Patients with Indolent Hematologic Malignancies
|
Robert Lowsky
|
Blood Cancer
|
|
|
Allogeneic Hematopoietic Cell Transplantation Using TLI/ATG for Older Patients with Hematologic Malignancies
|
Robert Lowsky
|
Blood Cancer
|
|
|
Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation
|
Robert S Negrin
|
Multiple Myeloma
|
|
|
TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD
|
Robert Lowsky
|
Myeloproliferative Disorders
Blood Cancer
Myelodysplastic Syndromes
|
|
|
Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma
|
Wen-Kai Weng
|
Lymphoma, Non-Hodgkin
|
|
|
A Pilot Study Evaluating the Immunologic Status of Patients with HER2+ Breast Cancer
|
Dr. Ellie Guardino MD/PhD
|
Breast Cancer
|
|
|
Identification and Characterization of Novel Proteins in Head and Neck Cancer
|
Quynh-Thu Le
|
Head and Neck Cancer
|
|
|
Study of Late-Occurring Complications in Childhood Cancer Survivors
|
Dr. Neyssa Marina
|
Leukemia
Sarcoma
Retinoblastoma
Lymphoma
Retinal Neoplasms
|
|
|
Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
|
Dr. Neyssa Marina
|
Leukemia
|
|
|
Healing Touch during Chemotherapy Infusions for Women with Breast Cancer
|
Kathy Turner RN, NP
Dr. Ellie Guardino MD/PhD
|
Breast Cancer
|
|
|
Molecular Analysis of Breast Cancer
|
Stefanie S. Jeffrey M.D.
|
Breast Cancer
|
|
|
Identification of Secreted Markers for Tumor Hypoxia in Patients with Head and Neck or Lung Cancers
|
Quynh-Thu Le
|
Head and Neck Cancer
Lip Neoplasms
Lip Cancer
Lung Cancer
|
|
|
Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients
|
Heather A. Wakelee
|
Lung Cancer
|
|
|
Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma
|
Glenn D. Rosen
Daya Upadhyay
|
Carcinoma, Giant Cell
Carcinoma, Non-Small-Cell Lung
|
|
|
Assessment of Health Related Quality of Life in Patients Treated for Rectal Cancer
|
Mark Lane Welton
|
Rectal Cancer
|
|
|
Research Sample Repository for Allogeneic Unrelated Hematopoietic Stem Cell Transplantation
|
Robert S Negrin
Judith Anne Shizuru
|
Leukemia, Myeloid
Lymphoma, Non-Hodgkin
Multiple Myeloma
|
|
|
QOL & Functional Outcomes After Combined Modality Tx for Anal CA: Comparison of Conventional vs IMRT
|
Mark Lane Welton
|
Anal Cancer
|
|
|
NMDP Research Database for Allogeneic Unrelated Hematopoietic Stem Cell Transplantation
|
David Miklos
|
Lymphoma, Non-Hodgkin
Leukemia, Lymphocytic
Multiple Myeloma
|
|
|
Sleep, Circadian Hormonal Dysregulation, and Breast Cancer Survival
|
David Spiegel
|
Breast Cancer
|
|
|
Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample
|
Irene L. Wapnir
|
Breast Cancer
Salivary Gland Neoplasms
Stomach Cancer
Thyroid Cancer
|
|
|
Allogeneic HCT using Nonmyeloablative Host Conditioning with TLI & ATG vs SOC in AML
|
Robert Lowsky
|
Leukemia, Myeloid
|
|
Study Title
|
Principal
Investigator |
Disease
Category |
|
A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
(No longer recruiting)
|
Steven Edward Coutre
|
Leukemia, Lymphocytic
Leukemia, B-Cell
|
|
Rituximab in Treating Patients With Hodgkin's Lymphoma
(No longer recruiting)
|
Sandra Jeane Horning
|
Lymphoma
|
|
Clinical Trial for Ovarian Cancer (OvaRex®)
(Terminated)
|
Nelson N Teng
|
Ovarian Cancer
|
|
Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer
(Completed)
|
Dr. Sandy Srinivas
|
Urologic Neoplasms
|
|
Rituximab, Combination Chemotherapy, and Bortezomib in Treating Patients With Untreated Mantle Cell Lymphoma
(No longer recruiting)
|
Sandra Jeane Horning
|
Lymphoma
|
|
Molecular Genetic Studies of Childhood Brain Tumors and Blood Samples
(Completed)
|
James M Ford
|
Brain Cancer
|
|
Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement
(No longer recruiting)
|
Clare J. Twist M.D.
|
Neuroblastoma
|
|
Perception of Burden, Uncertainty and Symptomatology in Caregivers of BMT Patients
(No longer recruiting)
|
Katherine Tierney
|
Carcinomas (including Squamous Cell and Adenocarcinoma)
|
|
Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma
(Completed)
|
Dr. Neyssa Maria Marina
|
Brain Cancer
|
|
Safety and Efficacy Study of the Trifunctional Antibody Catumaxomab to Treat Ovarian Cancer in Women After a Complete Response to Chemotherapy
(Completed)
|
Jonathan S. Berek MD, MMS
|
Ovarian Cancer
|
|
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
(No longer recruiting)
|
Irene L. Wapnir
|
Breast Cancer
|
|
Intellectual Impairment in Women With Breast Cancer
(Not yet recruiting)
|
Shelli Kesler
|
Breast Cancer
|
|
Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated w/RCHOP +/- XRT
(No longer recruiting)
|
Kristen N. Ganjoo
|
Lymphoma
Lymphoma, Non-Hodgkin
|
|
Treatment Protocol for the Use of Sorafenib in Patients With Advanced Renal Cell Carcinoma
(No longer recruiting)
|
Dr. Sandy Srinivas
|
Kidney Neoplasms
|
|
MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer
(Completed)
|
Dr. Sandy Srinivas
|
Prostatic Neoplasms
|
|
An Open Label Six Month Study to Evaluate the Safety and Efficacy of Nitrogen Mustard (NM) 0.04% Ointment Formulation in Patients With Stage I or IIA Mycosis Fungoides (MF) Who Have Completed an Initial 12 Month Treatment With Nitrogen Mustard 0.02% But Without a Complete Response
(inv )
|
Youn H Kim
|
Mycosis Fungoides
|
|
Study of TAC-101 as Second Line Treatment in Patients With Advanced Hepatocellular Carcinoma Who Received Sorafenib as First Line Therapy
(Terminated)
|
Samuel So
|
Carcinoma, Hepatocellular
|
|
Biomarker To Evaluate protein Profiles of neutropnic Fever/Infection with Acute or Chronic Leukemias
(No longer recruiting)
|
Jason Robert Gotlib
|
Leukemia, Myeloid
Leukemia, Lymphocytic
|
|
Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or Erlotinib
(No longer recruiting)
|
Heather A. Wakelee
|
Carcinoma, Non-Small-Cell Lung
|
|
Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer
(No longer recruiting)
|
Amreen Husain
|
Uterine Cervical Neoplasms
|
|
Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium
(No longer recruiting)
|
Dr. Sandy Srinivas
|
Ureteral Neoplasms
Kidney Neoplasms
Urethral Neoplasms
Bladder Cancer
|
|
A Study of Enzastaurin and Erlotinib in Patients With Solid Tumors and Lung Cancer
(No longer recruiting)
|
Heather A. Wakelee
|
Carcinoma, Non-Small-Cell Lung
Lung Diseases
Carcinomas (including Squamous Cell and Adenocarcinoma)
Thoracic Neoplasms
Neoplasms, Glandular and Epithelial
Lung Cancer
|
|
Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)for the Treatment of Myelodysplastic Syndromes (MDS)
(Suspended)
|
Peter L Greenberg
|
Neural Tube Defects
Bone Marrow Diseases
Thrombocytopenia
Lymphatic Diseases
Anemia
Precancerous Conditions
Myelodysplastic Syndromes
Preleukemia
Hematologic Diseases
|
|
A Phase II Study of AZD4877 (a Novel Anti-Mitotic Agent) in Advanced Bladder Cancer
(No longer recruiting)
|
Dr. Sandy Srinivas
|
Ureteral Neoplasms
Pelvic Neoplasms
Kidney Neoplasms
Urethral Neoplasms
Bladder Cancer
|
|
Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors
(Suspended)
|
Dr. Neyssa Marina
|
Sarcoma
|
|
Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma
(No longer recruiting)
|
Dr. Neyssa Marina
|
Sarcoma
|
|
A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-Resistant Prostate Cancer (IPI-504-04)
(No longer recruiting)
|
Dr. Sandy Srinivas
|
Prostatic Neoplasms
|
|
Phase 2 Study of GSK1363089 (Formerly XL880) in Adults With Squamous Cell Cancer of the Head and Neck
(Completed)
|
Dr. A. Dimitrios Colevas
|
Head and Neck Cancer
Carcinoma, Squamous Cell
|
|
R1507 in Patients With Recurrent or Refractory Sarcomas
(No longer recruiting)
|
Kristen N. Ganjoo
|
Sarcoma
|
|
Safety and Tolerability Study of SNS-314 for Advanced Solid Tumors
(Completed)
|
Ranjana Hira Advani
|
Carcinomas (including Squamous Cell and Adenocarcinoma)
|
|
A Phase 1b/2 Study of AMG 655 in Combination With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue Sarcoma
(No longer recruiting)
|
Kristen N. Ganjoo
|
Sarcoma
Neoplasm Metastasis
|
|
Evaluation of Pathwork Tissue of Origin (TOO) test for human malignancies
(Completed)
|
James L Zehnder
|
Neoplasm Metastasis
|
|
An Open-Label, Multicenter, Expanded Access Study of Oral AMN107 in Adult Patients With Imatinib (Glivec®/Gleevec®) - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase
(No longer recruiting)
|
Jason Robert Gotlib
|
Leukemia, Myeloid, Chronic
|
|
High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma
(No longer recruiting)
|
Dr. Neyssa Marina
|
Sarcoma
|
|
Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma
(No longer recruiting)
|
Kristen N. Ganjoo
|
Lymphoma, Non-Hodgkin
|
|
Study of YM155 in Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Subjects
(Terminated)
|
Sandra Jeane Horning
|
Lymphoma, B-Cell
Reticuloendotheliosis
Histiocytosis
Lymphoma, Large-Cell, Diffuse
|
|
Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma
(Terminated)
|
Ronald Levy
|
Lymphoma, Non-Hodgkin
Lymphoma, Follicular
|
|
Phase 1/2 Study of VELCADE®, Dexamethasone, and Revlimid® Versus VELCADE, Dexamethasone, Cyclophosphamide, and Revlimid in Patients With Previously Untreated Multiple Myeloma (EVOLUTION)
(Completed)
|
Bruno Carneiro de Medeiros
|
Multiple Myeloma
|
|
A Phase I/II Study of HKI-272 in Combination With Paclitaxel in Subjects With Advanced Solid Tumors and Breast Cancer
(No longer recruiting)
|
Branimir I Sikic
|
Breast Cancer
|
|
A Dose and Schedule Finding Trial With AMG 531 for CIT in Adults With Lymphoma
(Completed)
|
Ranjana Hira Advani
|
Lymphoma
Thrombocytopenia
Lymphoma, Non-Hodgkin
|
|
Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer
(No longer recruiting)
|
Quynh-Thu Le
|
Head and Neck Cancer
|
|
PR-104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer
(No longer recruiting)
|
Dr. A. Dimitrios Colevas
|
Lung Cancer
|
|
Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma
(Completed)
|
Harlan Pinto
|
Melanoma
Skin Cancers
|
|
Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell Lymphoma
(No longer recruiting)
|
Ranjana Hira Advani
|
Lymphoma
|
|
Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation
(Completed)
|
Dr. Neyssa Marina
|
Lymphoma
|
|
Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer
(No longer recruiting)
|
Harlan Pinto
|
Lung Cancer
|
|
Anastrozole and Gefitinib Compared With Fulvestrant and Gefitinib in Treating Postmenopausal Women With Recurrent or Metastatic Breast Cancer
(No longer recruiting)
|
Robert W Carlson
|
Breast Cancer
|
|
Diagnostic Study of Tumor Characteristics in Patients With Ewing's Sarcoma
(No longer recruiting)
|
Dr. Neyssa Marina
|
Sarcoma
|
|
Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors
(No longer recruiting)
|
Dr. Neyssa Marina
|
Central Nervous System Neoplasms
Neoplasms, Germ Cell and Embryonal
Brain Cancer
|
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma
(No longer recruiting)
|
Dr. Neyssa Marina
|
Central Nervous System Neoplasms
Ependymoma
Brain Cancer
|
|
Combination Chemotherapy in Treating Children or Adolescents With Newly Diagnosed Stage III or Stage IV Lymphoblastic Lymphoma
(Completed)
|
Dr. Neyssa Marina
|
Lymphoma
|
|
A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma
(Completed)
|
Dr. Sandy Srinivas
|
Kidney Neoplasms
|
|
Metabolic Imaging Predict Histopathologic Response to Preop ChemoXRT for Locally Advanced Rectal CA
(Terminated)
|
Albert Koong
|
Rectal Cancer
|
|
Calcitriol or Placebo in Men for Prostate Cancer Active Surveillance
(No longer recruiting)
|
Joseph C. Presti Jr.
|
Prostatic Neoplasms
|
|
A Phase II Trial of Calcitriol and Naproxen in Patients with Recurrent Prostate Cancer
(Suspended)
|
Dr. Sandy Srinivas
|
Prostatic Neoplasms
|
|
A Pilot Study Evaluating Oral Triamcinalone in Patients with Androgen Independent Prostate Cancer
(Completed)
|
Dr. Sandy Srinivas
|
Prostatic Neoplasms
|
|
Trilogy Stereotactic Body Radiotherapy for Pancreatic Cancer
(Completed)
|
Albert Koong
|
Pancreatic Cancer
|
|
Phase I/II PTK787/ZK 222584 and Gemcitabine in Advanced Pancreatic Cancer
(No longer recruiting)
|
George Albert Fisher M.D. Ph.D.
|
Pancreatic Cancer
|
|
Cyberknife Radiosurgery for Locally Advanced Pancreatic Cancer
(Completed)
|
Albert Koong
|
Pancreatic Cancer
|
|
Phase I/II Study of Intratumoral Injection of CPG 7909, a TLR9 Agonist, Combined with Local Radiation for Patients with Recurrent Mycosis Fungoides.
(Terminated)
|
Ronald Levy
|
Mycosis Fungoides
|
|
Phase I/II CPG 7909 + Local XRT in Recurrent Low-Grade Lymphomas
(No longer recruiting)
|
Ronald Levy
|
Lymphoma, Non-Hodgkin
|
|
Phase II trial of bevacizumab in combination with pemetrexed as 2nd line therapy in patients with stable brain metastases from non-small cell lung cancer
(No longer recruiting)
|
Heather A. Wakelee
|
Neoplasm Metastasis
Lung Cancer
|
|
Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung Cancer (excluding squamous cell)
(No longer recruiting)
|
Heather A. Wakelee
|
Lung Cancer
|
|
Evaluation of Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung Cancer
(No longer recruiting)
|
Dr. Billy W. Loo Jr. M.D. Ph.D.
|
Lung Cancer
|
|
Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers
(No longer recruiting)
|
Quynh-Thu Le
|
Lung Cancer
|
|
Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC
(No longer recruiting)
|
Heather A. Wakelee
|
Lung Cancer
|
|
Microarray Analysis of Gene Expression in Liver Tumors
(Completed)
|
Samuel So
|
Liver Cancer
|
|
Evaluation of Stereotactic Radiosurgery For Liver Malignancies
(Completed)
|
Albert Koong
|
Cholangiocarcinoma
Liver Cancer
Adenocarcinoma
|
|
Monoclonal Antibody (mAb) 216 with Chemotherapy in Adult Relapsed or Refractory B-Lineage Acute Lymphoblastic Leukemia
(No longer recruiting)
|
Steven Edward Coutre
|
Leukemia, Lymphocytic
|
|
Assessing the suitability of an imaging probe for use in clinical cell and gene therapy trials in cancer and rheumatoid arthritis
(No longer recruiting)
|
Sanjiv Sam Gambhir M.D., Ph.D.
|
Central Nervous System Neoplasms
Brain Cancer
Glioma
Arthritis, Rheumatoid
|
|
Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma
(Completed)
|
Iris Catrice Gibbs
|
Brain Cancer
|
|
Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission
(No longer recruiting)
|
Laura Johnston
|
Leukemia, Myelocytic, Acute
|
|
Transplantation for Patients with Chronic Lymphocytic Leukemia
(No longer recruiting)
|
Robert S Negrin
|
Leukemia, Lymphocytic, Chronic
|
|
High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma
(No longer recruiting)
|
Wen-Kai Weng
|
Lymphoma, Non-Hodgkin
|
|
Enrichment & Purging of Stem Cells in Non-Hodgkin's Lymphoma
(No longer recruiting)
|
Robert S Negrin
|
Lymphoma, Non-Hodgkin
|
|
Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies
(No longer recruiting)
|
Robert S Negrin
|
Myeloproliferative Disorders
Acute Disease
Leukemia, Myeloid, Chronic
Myelodysplastic Syndromes
|
|
Allo BMT in Advanced Leukemia or High Grade Lymphoma
(No longer recruiting)
|
Robert Lowsky
|
Lymphoma, Non-Hodgkin
|
|
Stem Cell Transplant From Matched Unrelated or Partially Matched Related Donors
(No longer recruiting)
|
Laura Johnston
|
Blood Cancer
|
|
Mixed Chimera Allo Transplantation in Multiple Myeloma
(No longer recruiting)
|
Wen-Kai Weng
|
Blood Cancer
Multiple Myeloma
|
|
Mixed Chimera Allogeneic Transplantation From Matched Unrelated Donors For The Treatment Of Multiple Myeloma
(Completed)
|
Robert Lowsky
|
Multiple Myeloma
|
|
Allogeneic Transplantation for Patients with Acute Leukemia or CML
(No longer recruiting)
|
Ginna Laport
|
Leukemia, Lymphocytic, Acute
|
|
Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic Cells
(Completed)
|
Ronald Levy
|
Multiple Myeloma
|
|
Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies
(No longer recruiting)
|
Sally Arai
|
Leukemia
Multiple Myeloma
|
|
High -Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma
(No longer recruiting)
|
Sally Arai
|
Multiple Myeloma
|
|
Stress, Diurnal Cortisol, and Breast Cancer Survival
(No longer recruiting)
|
David Spiegel
|
Breast Cancer
|
|
Estradiol Suppression for the treatment of metastatic breast cancer in premenopausal women
(No longer recruiting)
|
Robert W Carlson
|
Breast Cancer
|
|
Scintigraphic Assessment of I- Transport in Metastatic Breast Cancer and Evaluation of I31I Ablative Therapy: (Part I) Radioiodide Imaging Study
(Completed)
|
Irene L. Wapnir
|
Breast Cancer
|
|
Comprehensive Screening for Women at High Genetic Risk for Developing Breast Cancer
(No longer recruiting)
|
James M Ford
|
Breast Cancer
|
|
Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer
(No longer recruiting)
|
Frederick M. Dirbas
|
Breast Cancer
Carcinoma, Ductal
|
|
Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2
(No longer recruiting)
|
Stanley G Rockson
|
Breast Cancer
Lymphedema
|
|
Safety Study of Cetuximab in combination with Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer
(Completed)
|
George Albert Fisher M.D. Ph.D.
Branimir I Sikic
|
Rectal Cancer
|
|
Comparison of I-124 PET/CT, F-18 FDG PET/CT & I-123 whole body scintigraphy for recurrent thyroid CA
(No longer recruiting)
|
Iain Ross McDougall
Andrei Iagaru
|
Thyroid Cancer
|
|
Treatment Outcomes and Quality of Life after IMRT Treatments of Head and Neck Cancers
(No longer recruiting)
|
Quynh-Thu Le
|
Head and Neck Cancer
|
|
The Role of FDG PET in Radiation Treatment Planning for Head and Neck Cancers
(Completed)
|
Quynh-Thu Le
|
Head and Neck Cancer
|
|
Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based Contrast
(Completed)
|
Quynh-Thu Le
Dr. Billy W. Loo Jr. M.D. Ph.D.
|
Head and Neck Cancer
|
|
Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation
(No longer recruiting)
|
Quynh-Thu Le
Dr. Billy W. Loo Jr. M.D. Ph.D.
|
Head and Neck Cancer
Carcinoma, Squamous Cell
|
|
Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Neck
(Completed)
|
Quynh-Thu Le
|
Head and Neck Cancer
Carcinoma, Squamous Cell
|
|
Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer
(No longer recruiting)
|
Daniel T Chang
|
Esophageal Neoplasms
Adenocarcinoma
Carcinoma, Squamous Cell
|
|
Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
(No longer recruiting)
|
Sandra Jeane Horning
|
Lymphoma
|
|
Study of CEP-701 in Patients With Acute Myeloid Leukemia (AML)
(No longer recruiting)
|
Steven Edward Coutre
|
Leukemia
|
|
hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma
(Completed)
|
Dr. Neyssa Marina
|
Neuroblastoma
|
|
XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors
(Completed)
|
Dr Lawrence Recht
|
Brain Cancer
n Edema
|
|
Rituximab, Combination Chemotherapy, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Lymphoma
(No longer recruiting)
|
Sandra Jeane Horning
|
Lymphoma
|
|
Docetaxel With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
(No longer recruiting)
|
Harlan Pinto
|
Head and Neck Cancer
|
|
Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
(No longer recruiting)
|
Dr. Neyssa Marina
|
Central Nervous System Neoplasms
Brain Cancer
Glioma
|
|
Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes
(No longer recruiting)
|
Dr. Neyssa Marina
|
Leukemia
Myelodysplastic Syndromes
|
|
A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-Cell Lymphoma
(No longer recruiting)
|
Youn H Kim
|
Mycosis Fungoides
Lymphoma, T-Cell, Cutaneous
|
|
Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors
(Completed)
|
Dr. Neyssa Marina
|
Central Nervous System Neoplasms
|
|
Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer
(Completed)
|
Dr. Sandy Srinivas
|
Prostatic Neoplasms
|
|
Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides
(No longer recruiting)
|
Youn H Kim
|
Mycosis Fungoides
|
|
Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients
(No longer recruiting)
|
Gary V Dahl
|
Leukemia
Lymphoma
Tumor Lysis Syndrome
Hyperuricemia
|
|
A Phase 2 Clinical Trial of the Effectiveness of IRX-2 in Treating Patients With Operable Head and Neck Cancer
(No longer recruiting)
|
Dr Michael Kaplan
|
Head and Neck Cancer
Carcinoma, Squamous Cell
|
|
A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma
(No longer recruiting)
|
Ranjana Hira Advani
|
Lymphoma, T-Cell, Peripheral
|
|
Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia
(No longer recruiting)
|
Dr. Neyssa Marina
|
Leukemia
Lymphoma
Neuroblastoma
Medulloblastoma
|
|
Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms
(No longer recruiting)
|
Kristen N. Ganjoo
|
Lymphoma
|
|
Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
(Suspended)
|
Harlan Pinto
|
Colonic Neoplasms
Colon Cancer
|
|
An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies
(Completed)
|
Dr Lawrence Recht
|
Brain Cancer
|
|
XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema
(No longer recruiting)
|
Dr Lawrence Recht
|
Brain Cancer
n Edema
|
|
Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy
(Completed)
|
Joseph C. Presti Jr.
|
Bladder Cancer
|
|
Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
(No longer recruiting)
|
Quynh-Thu Le
|
haryngeal Neoplasms
|
|
Trial of AVN-944 in Patients With Advanced Hematologic Malignancies
(Completed)
|
Steven Edward Coutre
|
Leukemia
Waldenstrom Macroglobulinemia
Lymphoma, Non-Hodgkin
Multiple Myeloma
|
|
Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma
(No longer recruiting)
|
Sandra Jeane Horning
|
Lymphoma
|
|
A Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Treated Metastatic Breast Cancer (RIBBON 2)
(No longer recruiting)
|
Robert W Carlson
|
Breast Cancer
|
|
Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer
(Completed)
|
Heather A. Wakelee
|
Carcinoma, Small Cell
|
|
A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Blood Related Cancers
(No longer recruiting)
|
Jason Robert Gotlib
|
Leukemia
Mastocytosis, Systemic
Hypereosinophilic Syndrome
Mastocytosis
|
|
Second-Line Therapy Study For Potentially Platinum-Sensitive Relapsed Ovarian Cancer
(No longer recruiting)
|
Amreen Husain
|
Ovarian Cancer
|
|
Study of XL647 Administered Orally Daily to Patients With Solid Tumors
(No longer recruiting)
|
Branimir I Sikic
|
Cancer
|
|
Bortezomib, Ifosfamide, and Vinorelbine in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy
(Suspended)
|
Dr. Neyssa Marina
|
Lymphoma
|
|
Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian Cancer
(No longer recruiting)
|
Amreen Husain
|
Ovarian Cancer
|
|
Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients (MIMOSA)
(No longer recruiting)
|
Jonathan S. Berek MD, MMS
|
Ovarian Cancer
|
|
Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer
(No longer recruiting)
|
Amreen Husain
|
Uterine Cervical Neoplasms
|
|
Study of SGN-40 (Anti-huCD40 mAb) in Patients With Relapsed Diffuse Large B-Cell Lymphoma
(No longer recruiting)
|
Ranjana Hira Advani
|
Lymphoma, B-Cell
|
|
Study of Intravenously Administered SNS-032 in Patients With Advanced B-Lymphoid Malignancies
(No longer recruiting)
|
Steven Edward Coutre
|
Leukemia, Lymphocytic, Chronic
Multiple Myeloma
|
|
Rituximab, Combination Chemotherapy, and Bortezomib in Treating Patients With Untreated Mantle Cell Lymphoma
(No longer recruiting)
|
Sandra Jeane Horning
|
Lymphoma
Lymphoma, Mantle-Cell
|
|
Effect of Healing Touch on the Experience of Women Undergoing Treatment for Breast Cancer
(Completed)
|
Lynn m Westphal
|
Breast Cancer
|
|
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's Lymphoma
(Completed)
|
Sandra Jeane Horning
|
Lymphoma, Non-Hodgkin
|
|
Phase II/III Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III)
(No longer recruiting)
|
Dr Lawrence Recht
|
Central Nervous System Neoplasms
Brain Cancer
Glioblastoma
|
|
Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic Cancer
(Completed)
|
George Albert Fisher M.D. Ph.D.
Edgar G Engleman
|
Pancreatic Cancer
|
|
Hypofractionated Radiotherapy for Localized Prostate Cancer (with CyberKnife or with IMRT)
(Completed)
|
Christopher R. King
|
Prostatic Neoplasms
|
|
Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx
(Completed)
|
Albert Koong
|
Pancreatic Cancer
|
|
First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
(Completed)
|
Dr. Sandy Srinivas
|
Carcinoma, Transitional Cell
Bladder Cancer
|
|
Endoscopic Capillary Oximetry for Tumor Diagnosis in Head and Neck Cancer
(No longer recruiting)
|
Peter Maxim PhD
|
Head and Neck Cancer
|
|
A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Palifermin (rHuKGF) in the Reduction of Acute Graft Versus Host Disease in Subjects With Hematologic Malignancies Undergoing Allogeneic Marrow/PBPC Transplantation
(Completed)
|
Ginna Laport
|
Graft vs Host Disease
Blood Cancer
|
|
Evaluation of Preexisiting Immunity Markers in Human Tumor Tissue Sample
(No longer recruiting)
|
Jeffrey A. Norton
|
Cancer
|
|
Repeat-Dose of Forodesine Hydrochloride (BCX-1777) Infusion in Patients With Advanced T-Cell Leukemia
(Completed)
|
Gary V Dahl
|
Leukemia, T-Cell
|
|
Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus
(Suspended)
|
Amreen Husain
|
Leiomyosarcoma
|
|
Phase 2 Trial of Enzastaurin in Prostate Cancer in Patients Who Have Had Hormonal and Chemotherapy
(No longer recruiting)
|
Dr. Sandy Srinivas
|
Prostatic Neoplasms
|
|
"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk
(No longer recruiting)
|
Harcharan Gill
|
Urogenital Cancer
Prostatic Neoplasms
Genital Diseases, Male
|
|
Correlation of PET-CT Studies with Serum Protein Analysis
(Completed)
|
Dr Andrew Quon
|
Carcinomas (including Squamous Cell and Adenocarcinoma)
|
|
Carboplatin and Paclitaxel With or Without Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Melanoma
(No longer recruiting)
|
Harlan Pinto
|
Melanoma
Skin Cancers
|
|
Ph 3 Open-label KOS953+Bortezomib compared to Bortezomib for First Relapse MM
(Suspended)
|
Bruno Carneiro de Medeiros
|
Multiple Myeloma
|
|
A Study Evaluating the Efficacy and Safety of Sutinib With or Without Bevacizumab in First-Line Patients With Metastatic Renal Cell Cancer (SABRE-R)
(No longer recruiting)
|
Dr. Sandy Srinivas
|
Kidney Neoplasms
Carcinoma, Renal Cell
|
|
A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Metastatic Breast Cancer
(No longer recruiting)
|
Dr. Ellie Guardino MD/PhD
|
Breast Cancer
|
|
Trial Administration